Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in Dis Esophagus Retrieve available abstracts of 129 articles: HTML format

Single Articles

October 2025
1. MATSUDA S, Wijnhoven B, Lordick F, Bhandari P, et al
   Quality indicator survey of clinical practice guidelines for esophagogastric junction cancer 2023.
   Dis Esophagus. 2025;38:doaf071.
   PubMed     Abstract available
   
   
   September 2025
2. 
   Correction to: The prevalence, nature and severity of oropharyngeal dysphagia in the acute post-operative phase following curative resection for esophageal cancer.
   Dis Esophagus. 2025;38:doaf074.
   PubMed    
   
   
   
3. STRAATMAN J, Abu Hejley A, Klevebro F, Fuchs H, et al
   Analysis of in-hospital mortality following transthoracic esophagectomy for cancer.
   Dis Esophagus. 2025;38:doaf076.
   PubMed     Abstract available
   
   
   
4. KOOIJ CD, Goense L, Kingma BF, den Boer RB, et al
   Early versus late oral feeding regimens following esophagectomy: a propensity score-matched observational cohort.
   Dis Esophagus. 2025;38:doaf068.
   PubMed     Abstract available
   
   
   
5. DE MUL N, Vernooij LM, van Haastregt NCJ, de Groot EM, et al
   Judicious use of critical care resources by predicting the need for routine ICU admission following esophagectomy.
   Dis Esophagus. 2025;38:doaf075.
   PubMed     Abstract available
   
   
   
6. SEURS W, Van Veer H, Nafteux P, Depypere L, et al
   Are insufficient diagnostic criteria for anastomotic leakage after esophagectomy harming our patients?
   Dis Esophagus. 2025;38:doaf081.
   PubMed     Abstract available
   
   
   July 2025
7. HAYES M, Gillman A, Elliott JA, Donohoe CL, et al
   The prevalence, nature and severity of oropharyngeal dysphagia in the acute post-operative phase following curative resection for esophageal cancer.
   Dis Esophagus. 2025;38:doaf054.
   PubMed     Abstract available
   
   
   
8. WATANABE Y, Iida M, Nishiyama M, Nakashima C, et al
   Preoperative sarcopenia predicts complications and non-cancer specific mortality in esophageal cancer surgery.
   Dis Esophagus. 2025;38:doaf056.
   PubMed     Abstract available
   
   
   
9. TRUIJEN SPM, Vissers PAJ, Nieuwenhuijzen GAP, van der Sangen MJC, et al
   A cost-effectiveness analysis of the effect of hospital variation in the probability of providing treatment with curative intent in potentially curable esophageal and gastric cancer patients.
   Dis Esophagus. 2025;38:doaf057.
   PubMed     Abstract available
   
   
   
10. FENG Z, Li M, Cui B, Wang L, et al
    Patterns of toxic side effects and prognostic factors in concurrent chemoradiotherapy for esophageal cancer.
    Dis Esophagus. 2025;38:doaf060.
    PubMed     Abstract available
    
    
    
11. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Development of a symptom response to treatment questionnaire for patients in follow-up after oesophago-gastrectomy for cancer.
    Dis Esophagus. 2025;38:doaf063.
    PubMed     Abstract available
    
    
    
12. DEN BOER RB, Sanders ME, Meijer GJ, Haj Mohammad N, et al
    Impact of endoscopic ultrasonography with fine needle aspiration assessing clinical lymph node staging on radiotherapy treatment planning in esophageal cancer patients.
    Dis Esophagus. 2025;38:doaf065.
    PubMed     Abstract available
    
    
    
13. KO MT, Rizwanullah A, Jafri Z, Fung A, et al
    Chemoprevention of Barrett's Esophagus: a Systematic Review and Comprehensive Assessment of Bias.
    Dis Esophagus. 2025;38:doaf062.
    PubMed     Abstract available
    
    
    
14. KEMPF ON, Thorsen LBJ, Nerup N, Kjaer DW, et al
    Stage-dependent survival in esophageal cancer: a Danish nationwide cohort study.
    Dis Esophagus. 2025;38:doaf064.
    PubMed     Abstract available
    
    
    
15. CHEVALLAY M, Barman S, Moss C, Van Hemelrijck M, et al
    Impact of endoscopic pyloric dilatation on symptom relief in delayed gastric emptying after esophageal resection-use of a novel symptom response questionnaire.
    Dis Esophagus. 2025;38:doaf067.
    PubMed     Abstract available
    
    
    
16. TANKEL J, Amin S, Katz A, Sakalla R, et al
    Gastric conduit necrosis following esophagectomy: is conduit salvage feasible?
    Dis Esophagus. 2025;38:doaf066.
    PubMed     Abstract available
    
    
    May 2025
17. ZHU G, Song X, Wang Q, Zhang Z, et al
    Effects of immunoenteric nutrition versus general enteral nutrition on prognosis in patients with squamous cell carcinoma undergoing radical esophagectomy post neoadjuvant chemotherapy.
    Dis Esophagus. 2025;38:doaf027.
    PubMed     Abstract available
    
    
    
18. WANG M, Wang X, Liu Z, Shen H, et al
    Recurrence patterns following neoadjuvant chemotherapy combined with immunotherapy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf034.
    PubMed     Abstract available
    
    
    
19. RICCIO F, Klarenbeek BR, Fujiwara H, Seto Y, et al
    Worldwide survey on the transcervical approach for minimally invasive treatment of esophageal cancer: results of questionnaire of the international collaborative group on transCervical Minimally Invasive Esophagectomy.
    Dis Esophagus. 2025;38:doaf035.
    PubMed     Abstract available
    
    
    
20. CHIEN S, Glen P
    Impact on Barrett's dysplasia yield following the introduction of capsule sponge testing versus traditional endoscopic surveillance.
    Dis Esophagus. 2025;38:doaf033.
    PubMed     Abstract available
    
    
    
21. VISSAPRAGADA R, Bulamu NB, Whiteman DC, Bright T, et al
    Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett's esophagus.
    Dis Esophagus. 2025;38:doaf038.
    PubMed     Abstract available
    
    
    
22. DAMTOFT A, Osterkamp J, Olsen AA, De Heer P, et al
    Incidence of delayed gastric conduit emptying after esophagectomy: a retrospective single-center study.
    Dis Esophagus. 2025;38:doaf040.
    PubMed     Abstract available
    
    
    
23. KOOIJ CD, de Groot EM, Goense L, Kingma BF, et al
    The effect of prophylactic cruroplasty on the incidence of hiatal herniation after robot-assisted minimally invasive esophagectomy (RAMIE).
    Dis Esophagus. 2025;38:doaf041.
    PubMed     Abstract available
    
    
    
24. MARTINS BC, Gregorio JM, Sueta RU, Centeno DM, et al
    Efficacy and safety of self-expanding metal stents in advanced esophageal cancer: a 12-year analysis in a referral center.
    Dis Esophagus. 2025;38:doaf039.
    PubMed     Abstract available
    
    
    
25. LV Z, Yuan L, Mao Y, Ai S, et al
    Recurrent laryngeal nerve paralysis as a potential mediator of complications in esophagectomy following lymph node dissection.
    Dis Esophagus. 2025;38:doaf028.
    PubMed     Abstract available
    
    
    
26. HARRIS TR, Elkamel AAA, Wang K, Abdalgadir M, et al
    Predictors of overall survival in esophageal cancer patients with pathologic complete response after neoadjuvant therapy and surgery.
    Dis Esophagus. 2025;38:doaf043.
    PubMed     Abstract available
    
    
    
27. CRUMP T, Dehghani M, Sutherland JM, Mueller C, et al
    Calculating the minimally important difference for the FACT-E from esophageal cancer surgery to recovery using distribution-based methods.
    Dis Esophagus. 2025;38:doaf042.
    PubMed     Abstract available
    
    
    
28. SUGASE T, Kanemura T, Matsuura N, Sugimura K, et al
    Clinical outcomes of pembrolizumab plus chemotherapy for postoperative recurrent esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf029.
    PubMed     Abstract available
    
    
    
29. LYE TJ, Chiu CH, Chao YK
    Association between recurrent laryngeal nerve diameter and postoperative palsy following robot-assisted minimally invasive esophagectomy.
    Dis Esophagus. 2025;38:doaf048.
    PubMed     Abstract available
    
    
    
30. MARKAR SR, Van Berge Henegouwen M, Bruns C, Ferri L, et al
    Does the SANO trial really move us toward organ preservation for esophageal cancer?
    Dis Esophagus. 2025;38:doaf049.
    PubMed    
    
    
    
31. YANG P, Xue B, Liu T, Qi L, et al
    Prognostic impact of recurrent laryngeal nerve lymph node metastatic status in thoracic esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf052.
    PubMed     Abstract available
    
    
    March 2025
32. MUCHA AW, Strandby RB, Nerup NA, Achiam MP, et al
    Treatment of intrathoracic anastomotic leakage following esophagectomy for gastroesophageal cancer: a systematic review.
    Dis Esophagus. 2025;38:doaf016.
    PubMed     Abstract available
    
    
    
33. LIU D, Liang HW, Liu Y, Huang W, et al
    Causes of death in locally advanced esophageal cancer undergoing neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy: a retrospective cohort study.
    Dis Esophagus. 2025;38:doaf017.
    PubMed     Abstract available
    
    
    
34. NG AYL, Goense L, Van De Horst S, Van Den Berg JW, et al
    Robotic- assisted minimally invasive Ivor-Lewis handsewn anastomosis technique and outcomes from a large-volume European centre.
    Dis Esophagus. 2025;38:doaf019.
    PubMed     Abstract available
    
    
    
35. SAEED U, Myklebust TA, Robsahm TE, Aune D, et al
    Associations between body mass index and gastroesophageal cancer incidence and mortality: novel insights from a nationwide registry-based cohort study.
    Dis Esophagus. 2025;38:doaf018.
    PubMed     Abstract available
    
    
    January 2025
36. KENNELLY P, Davey MG, Griniouk D, Calpin G, et al
    Evaluating the impact of enhanced recovery after surgery protocols following oesophagectomy: a systematic review and meta-analysis of randomised clinical trials.
    Dis Esophagus. 2025;38:doae118.
    PubMed     Abstract available
    
    
    
37. TAKEBAYASHI K, Kaida S, Otake R, Fukuo A, et al
    HMB/Arg/Gln may improve short-term outcomes after esophagectomy in patients with thoracic esophageal cancer.
    Dis Esophagus. 2025;38:doae121.
    PubMed     Abstract available
    
    
    
38. ZHOU MJ, Hsing AW, Clarke JO
    Prevalence and predictors of Barrett's esophagus and esophageal cancer in patients with eosinophilic esophagitis.
    Dis Esophagus. 2025;38:doae120.
    PubMed     Abstract available
    
    
    
39. TRAVIS D, Nnawuba K, Vellanki S, Robinson S, et al
    Demographic analysis of survival trends in squamous cell carcinoma of the upper 1/3 of the esophagus: a population-based study.
    Dis Esophagus. 2025;38:doae111.
    PubMed     Abstract available
    
    
    
40. OSTERKAMP JTF, Nerup N, Svendsen MBS, Strandby RB, et al
    Central ligation or partial preservation of the right gastric artery does not seem to affect conduit or anastomotic perfusion during robot-assisted resection of gastroesophageal junction cancer: a randomized clinical trial.
    Dis Esophagus. 2025;38:doae102.
    PubMed     Abstract available
    
    
    
41. GEERTS JFM, van den Berg I, van Nistelrooij AMJ, Lagarde SM, et al
    Risk factors for readmission following esophagectomy and gastrectomy for cancer.
    Dis Esophagus. 2025;38:doae101.
    PubMed     Abstract available
    
    
    
42. OKUMURA T, Miwa T, Murotani K, Numata Y, et al
    Modified reconstruction procedure in subtotal esophagectomy with retrosternal gastric pull up to reduce anastomotic leakage: a propensity score-matched analysis.
    Dis Esophagus. 2025;38:doae100.
    PubMed     Abstract available
    
    
    
43. CAUSH L, Church J, Goodall S, Lord RV, et al
    Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia in Australia.
    Dis Esophagus. 2025;38:doae095.
    PubMed     Abstract available
    
    
    
44. IGAUE S, Nozaki R, Utsunomiya D, Kubo Y, et al
    Treatment strategy involving docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery for locally advanced unresectable/borderline resectable esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doae114.
    PubMed     Abstract available
    
    
    
45. MARKAR S, Mariette C, Bonnetain F, Lundell L, et al
    Immunonutrition to improve the quality of life of upper gastrointestinal cancer patients undergoing neoadjuvant treatment prior to surgery (NEOIMMUNE): double-blind randomized controlled multicenter clinical trial.
    Dis Esophagus. 2025;38:doae113.
    PubMed     Abstract available
    
    
    
46. WALMSLEY JA, Abdelrahman M, Ariyarathenam A, Berrisford R, et al
    Prognostic significance of subcarinal lymph node involvement in patients with Siewert type I and II gastro-esophageal junctional adenocarcinoma: an analysis of 698 patients undergoing Ivor-Lewis esophagectomy.
    Dis Esophagus. 2025;38:doaf003.
    PubMed     Abstract available
    
    
    
47. YANG T, Yang P, Li H, Sun M, et al
    Association of treatment methods and survival in esophageal neuroendocrine carcinoma population of Surveillance, Epidemiology, and End Results database: a retrospective cohort study.
    Dis Esophagus. 2025;38:doaf008.
    PubMed     Abstract available
    
    
    
48. ZHENG B, Huang G, Zeng T, Zhang S, et al
    Optimal extent of left recurrent laryngeal nerve para-lymph node dissection in esophageal squamous cell carcinoma: a retrospective analysis based on cytokeratin 19 immunopositivity for micrometastasis detection.
    Dis Esophagus. 2025;38:doae106.
    PubMed     Abstract available
    
    
    
49. ROMPEN IF, Yilmazcelik B, Crnovrsanin N, Schiefer S, et al
    Minimally invasive resection is associated with decreased occurrence of early delayed gastric conduit emptying after Ivor-Lewis esophagectomy.
    Dis Esophagus. 2025;38:doaf006.
    PubMed     Abstract available
    
    
    
50. YE W, Leng C, Chen J, Mai Z, et al
    Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study.
    Dis Esophagus. 2025;38:doaf009.
    PubMed     Abstract available
    
    
    
51. YAGI K, Aikou S, Yajima S, Urabe M, et al
    Survival outcomes of robot-assisted transmediastinal esophagectomy in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2025;38:doaf007.
    PubMed     Abstract available
    
    
    
52. KURIYAMA K, Okamura A, Hayami M, Kanamori J, et al
    Is prophylactic lymph node dissection efficacious in salvage esophagectomy after definitive chemoradiotherapy?
    Dis Esophagus. 2025;38:doaf004.
    PubMed     Abstract available
    
    
    
53. ZHOU G, Ding X, Wang M, Tong Y, et al
    Feasibility and safety of interventional radiology-guided biopsy for esophageal stenosis.
    Dis Esophagus. 2025;38:doaf005.
    PubMed     Abstract available
    
    
    
54. LUO B, Yang Y, Huang Y
    A preliminary investigation of blood cell counts for esophageal cancer screening: differentiating esophageal cancer from gastroesophageal reflux disease.
    Dis Esophagus. 2025;38:doaf025.
    PubMed     Abstract available
    
    
    December 2024
55. TERAYAMA M, Okamura A, Oki A, Kuriyama K, et al
    Predictive factors for failure of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy in esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 Dec 19:doae115. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. PEYSER CARDOSO R, Agarwal L, Cardoso SA, Agarwal A, et al
    Impact of intraoperative recurrent laryngeal nerve monitoring on minimally invasive esophagectomy outcomes for esophageal cancer: a meta-analysis of case-control studies.
    Dis Esophagus. 2024 Dec 19:doae116. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. KWON Y, Yun JK, Lee GD, Choi SH, et al
    Gastric conduit in patients with previous endoscopic resection of the stomach for esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 Dec 7:doae112. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
58. CHEN J, Wang Z, Huang J, Zhang Y, et al
    Experimental study on radiational characteristics and nursing care of a novel radioisotope 188Re memory alloy esophageal stent.
    Dis Esophagus. 2024;37:doae088.
    PubMed     Abstract available
    
    
    
59. MINAKATA N, Kadota T, Sakashita S, Inaba A, et al
    Tumor thickness is associated with metastasis in patients with submucosal invasive adenocarcinoma of the esophagogastric junction.
    Dis Esophagus. 2024;37:doae083.
    PubMed     Abstract available
    
    
    
60. MOONS J, Declerck H, Gijbels E, Jans M, et al
    Evaluation of patient satisfaction with an enhanced recovery protocol for esophageal resections: a concurrent quantitative and qualitative analysis.
    Dis Esophagus. 2024;37:doae079.
    PubMed     Abstract available
    
    
    
61. DONATO BB, Campany ME, Brady JT, Jenkins JA, et al
    Complete pathologic response in esophageal adenocarcinoma: does it make a difference?
    Dis Esophagus. 2024;37:doae068.
    PubMed     Abstract available
    
    
    
62. ROSMOLEN WD, Pouw RE, Bergman JJ, Sprangers MAG, et al
    Reasons for fear of cancer recurrence after endoscopic treatment of T1 esophageal adenocarcinoma. A semi-structured interview study.
    Dis Esophagus. 2024;37:doae067.
    PubMed     Abstract available
    
    
    
63. LIU C, Lan TL, Tsai PC, Chien LI, et al
    Managing esophageal squamous cell carcinoma after cervical radiotherapy for a head and neck cancer: esophagectomy remains a viable option.
    Dis Esophagus. 2024 Nov 7:doae099. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. HARADA T, Tsuji T, Ueno J, Konishi N, et al
    Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort study.
    Dis Esophagus. 2024 Nov 5:doae096. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
65. BEVERS KC, Sewell M, Bott MJ, Sihag S, et al
    Gastric preconditioning via percutaneous angioembolization before esophagectomy in patients at high risk for esophageal leak.
    Dis Esophagus. 2024;37:doae062.
    PubMed     Abstract available
    
    
    
66. BLONK L, Gooszen JAH, Fakkert RA, Eshuis WJ, et al
    Micronutrient deficiencies and anemia in the follow-up after gastroesophageal cancer surgery.
    Dis Esophagus. 2024;37:doae053.
    PubMed     Abstract available
    
    
    
67. AHMED R, Elliott JA, Blaser M, Donohoe CL, et al
    Paraconduit hiatus hernia after esophageal cancer surgery: incidence, risk factors, and management.
    Dis Esophagus. 2024 Oct 28:doae093. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. SAWAI S, Nakatani E, Sato S, Hawke P, et al
    Peak expiratory flow predicts the occurrence of postoperative pneumonia after esophagectomy for esophageal cancer.
    Dis Esophagus. 2024 Oct 10:doae084. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. PATTON A, Davey MG, Quinn E, Reinhardt C, et al
    Minimally invasive vs open vs hybrid esophagectomy for esophageal cancer: a systematic review and network meta-analysis.
    Dis Esophagus. 2024 Oct 10:doae086. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. ST-PIERRE J, Coca-Martinez M, Drummond K, Minnella E, et al
    Multimodal prehabilitation to enhance functional capacity of patients with esophageal cancer during concurrent neoadjuvant chemotherapies-a randomized feasibility trial.
    Dis Esophagus. 2024 Oct 8:doae087. doi: 10.1093.
    PubMed     Abstract available
    
    
    
71. TANKEL J, Nevo Y, Al Shehhi R, Sakalla R, et al
    Impact of bulky loco-regional lymphadenopathy in esophageal adenocarcinoma on survival: a retrospective single center analysis.
    Dis Esophagus. 2024;37:doae046.
    PubMed     Abstract available
    
    
    
72. LOUGHNEY L, Murphy K, Tully R, Robb WB, et al
    The effect of a pre- and post-operative exercise program versus standard care on physical activity and sedentary behavior of patients with esophageal and gastric cancer undergoing neoadjuvant treatment prior to surgery (the PERIOP-OG Trial): a randomi
    Dis Esophagus. 2024;37:doae044.
    PubMed     Abstract available
    
    
    
73. WATANABE M, Takahashi N, Tamura M, Terayama M, et al
    Gastric conduit reconstruction after esophagectomy.
    Dis Esophagus. 2024;37:doae045.
    PubMed     Abstract available
    
    
    September 2024
74. HAMRAH MH, Kanda M, Sato Y, Zhu H, et al
    Expression profile and function of secretogranin V, and its effects on the malignant behavior of esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 Sep 26:doae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
75. HAUGE T, Dretvik T, Johnson E, Mala T, et al
    Treatment of anastomotic leakage following Ivor Lewis esophagectomy-10 year experience from a Nordic center.
    Dis Esophagus. 2024;37:doae040.
    PubMed     Abstract available
    
    
    
76. KLEVEBRO F, Ash S, Mueller C, Garbarino GM, et al
    Contemporary outcomes of left thoraco-abdominal esophagectomy due to cancer in the esophagus or gastroesophageal junction, a multicenter cohort study.
    Dis Esophagus. 2024;37:doae039.
    PubMed     Abstract available
    
    
    
77. SUZUKI Y, Kikuchi D, Nakamura S, Iizuka T, et al
    Endoscopic submucosal dissection for superficial esophageal cancer in the remnant esophagus after esophagectomy.
    Dis Esophagus. 2024 Aug 26:doae070. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. LIU C, Tsai PC, Chien LI, Huang CS, et al
    Esophagectomy in patients with esophageal squamous cell carcinoma and distant nodal metastasis.
    Dis Esophagus. 2024 Aug 16:doae064. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. LV Z, Yuan L, He J, Gao S, et al
    Time-dependent prognostic impact of circumferential resection margin in T3 thoracic esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 Aug 14:doae065. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. LIATSOU E, Bellos I, Katsaros I, Michailidou S, et al
    Sex differences in survival following surgery for esophageal cancer: A systematic review and meta-analysis.
    Dis Esophagus. 2024 Aug 14:doae063. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. LINDBLAD M, Jestin C, Johansson J, Edholm D, et al
    Multidisciplinary team meetings improve survival in patients with esophageal cancer.
    Dis Esophagus. 2024 Aug 9:doae061. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. VAN GEFFEN EGM, Neelis KJ, Putter H, Slingerland M, et al
    Esophagectomy after definitive chemoradiation in esophageal cancer: a safe therapeutic strategy.
    Dis Esophagus. 2024 Aug 8:doae059. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. SHIGENO T, Otomo M, Kajiyama D, Sato K, et al
    Assessing the outcomes of posterior thoracic para-aortic lymph node dissection after induction chemotherapy in patients with esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 Aug 2:doae060. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2024
84. NORTON BC, Aslam N, Telese A, Papaefthymiou A, et al
    Risk of metastasis among patients diagnosed with high-risk T1 esophageal adenocarcinoma who underwent endoscopic follow-up.
    Dis Esophagus. 2024;37:doae027.
    PubMed     Abstract available
    
    
    
85. PAPACONSTANTINOU D, Koliakos N, Tzortzis AS, Mandrakas N, et al
    Role of thoracic endovascular aortic repair in T4b esophageal cancer management: a systematic review.
    Dis Esophagus. 2024 Jul 26:doae058. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. 
    Correction to: Performance of a consensus-based algorithm for diagnosing anastomotic leak after minimally invasive esophagectomy for esophageal cancer.
    Dis Esophagus. 2024 Jul 5:doae056. doi: 10.1093.
    PubMed    
    
    
    
87. KANG CH, Yun TY, Park JH, Na B, et al
    Long-term survival analysis of robotic esophagectomy for esophageal cancer.
    Dis Esophagus. 2024 Jul 4:doae054. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. VELAYUDHAM GK, Dermanis A, Kamarajah SK, Griffiths EA, et al
    Predictors of textbook outcome following oesophagogastric cancer surgery.
    Dis Esophagus. 2024;37:doae023.
    PubMed     Abstract available
    
    
    
89. WIJNHOVEN BPL, Griffiths EA
    Diagnosis and treatment of junctional cancer from a global perspective.
    Dis Esophagus. 2024;37:doae017.
    PubMed    
    
    
    June 2024
90. WANG CZ, Zhang HL, Shang QX, Gu YM, et al
    Mapping of lymph node metastasis from esophageal squamous cell carcinoma after neoadjuvant treatment: a prospective analysis from a high-volume institution in China.
    Dis Esophagus. 2024 Jun 17:doae052. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. TANAKA I, Hatta W, Koike T, Takahashi S, et al
    Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer.
    Dis Esophagus. 2024 Jun 13:doae048. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. VAN DER ZIJDEN CJ, Bouwman A, Mostert B, Nuyttens JJME, et al
    Overall survival after definitive chemoradiotherapy for patients with esophageal cancer: a retrospective cohort study.
    Dis Esophagus. 2024 Jun 5:doae047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
93. REDDY AT, Lee JP, Leiman DA
    Measuring and improving quality in esophageal care and swallowing disorders.
    Dis Esophagus. 2024;37:doae013.
    PubMed     Abstract available
    
    
    
94. NGUYEN CL, Tovmassian D, Isaacs A, Falk GL, et al
    Risk of lymph node metastasis in T1 esophageal adenocarcinoma: a meta-analysis.
    Dis Esophagus. 2024;37:doae012.
    PubMed     Abstract available
    
    
    
95. HEDBERG J, Sundbom M, Edholm D, Aahlin EK, et al
    Randomized controlled trial of nasogastric tube use after esophagectomy: study protocol for the kinetic trial.
    Dis Esophagus. 2024;37:doae010.
    PubMed     Abstract available
    
    
    May 2024
96. SHIRAISHI O, Hagi T, Hiraki Y, Kato H, et al
    Risk factors and prognosis for supraclavicular lymph node metastasis in patients with thoracic esophageal cancer. Distant or regional metastasis?
    Dis Esophagus. 2024 May 14:doae042. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. MIYATA H, Sugimura K, Kanemura T, Takeoka T, et al
    Prognostic impact of nodal status and lymphovascular invasion in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
    Dis Esophagus. 2024 May 1:doae038. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
98. CHIEN S, Glen P, Penman I, Bryce G, et al
    National adoption of an esophageal cell collection device for Barrett's esophagus surveillance: impact on delay to investigation and pathological findings.
    Dis Esophagus. 2024;37:doae002.
    PubMed     Abstract available
    
    
    
99. VISSER MR, van Berge Henegouwen MI, van Hillegersberg R
    Centralization and Quality Control in Esophageal Cancer Surgery: a Way Forward in Europe.
    Dis Esophagus. 2024 Apr 26:doae035. doi: 10.1093.
    PubMed    
    
    
    
100. VISSER MR, Voeten DM, Gisbertz SS, Ruurda JP, et al
     Western European Variation in the Organization of Esophageal Cancer Surgical Care.
     Dis Esophagus. 2024 Apr 26:doae033. doi: 10.1093.
     PubMed     Abstract available
     
     
     
101. MATSUMOTO S, Wakatsuki K, Nakade H, Kunishige T, et al
     Association of perioperative oral swallowing function with post-esophagectomy outcomes and nutritional statuses in patients with esophageal cancer.
     Dis Esophagus. 2024 Apr 25:doae032. doi: 10.1093.
     PubMed     Abstract available
     
     
     
102. JEON YJ, Han K, Lee SW, Lee JE, et al
     Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study.
     Dis Esophagus. 2024 Apr 8:doae029. doi: 10.1093.
     PubMed     Abstract available
     
     
     
103. ZHANG GL, Zhu QK, Ma TY, Weng CG, et al
     Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma.
     Dis Esophagus. 2024;37:doad073.
     PubMed     Abstract available
     
     
     
104. YUNRONG T, Jin WW, Mahendran HA, Koon YB, et al
     Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications.
     Dis Esophagus. 2024;37:doad072.
     PubMed     Abstract available
     
     
     March 2024
105. PEI S, Huang JQ, Liang HW, Liu Y, et al
     Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery.
     Dis Esophagus. 2024 Mar 28:doae026. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. FURUE Y, Yoda Y, Hori K, Nakajo K, et al
     Outcomes of repeated endoscopic submucosal dissection for superficial Esophageal squamous cell carcinoma on endoscopic resection scar.
     Dis Esophagus. 2024 Mar 28:doae018. doi: 10.1093.
     PubMed     Abstract available
     
     
     
107. PATEL J, Khanna T, Sohal A, Dhaliwal A, et al
     Impact of aspirin use on rates of metastasis in patients with esophageal cancer: insights from the National Inpatient Sample.
     Dis Esophagus. 2024 Mar 24:doae022. doi: 10.1093.
     PubMed     Abstract available
     
     
     
108. BABIC B, Mueller DT, Krones TL, Schiffmann LM, et al
     A senior surgical resident can safely perform complex esophageal cancer surgery after surgical mentoring program-experience of a European high-volume center.
     Dis Esophagus. 2024 Mar 8:doae015. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
109. AN KR, Seijas V, Xu MS, Grusser L, et al
     Does prehabilitation before esophagectomy improve postoperative outcomes? A systematic review and meta-analysis.
     Dis Esophagus. 2024;37:doad066.
     PubMed     Abstract available
     
     
     
110. PELZNER K, Fuchs C, Petersen M, Maus M, et al
     Sex- and gender-specific differences in symptoms and health-related quality of life among patients with gastroesophageal reflux disease.
     Dis Esophagus. 2024;37:doad064.
     PubMed     Abstract available
     
     
     January 2024
111. MENGARDO V, Weindelmayer J, Ceccherini G, Wilkinson M, et al
     The effect of aging on short- and long-term results after esophagectomy: an international multicenter retrospective analysis.
     Dis Esophagus. 2024;37:doad057.
     PubMed     Abstract available
     
     
     
112. THAMMINEEDI SR, Patnaik SC, Nusrath S, Naik V, et al
     Evaluation of indocyanine green tracheobronchial fluorescence (ICG-TBF) via nebulization during minimally invasive esophagectomy.
     Dis Esophagus. 2024;37:doad059.
     PubMed     Abstract available
     
     
     
113. GILLMAN A, Kenny C, Hayes M, Walshe M, et al
     Nature, severity, and impact of chronic oropharyngeal dysphagia following curative resection for esophageal cancer: a cross-sectional study.
     Dis Esophagus. 2024 Jan 23:doae003. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. CHO H, Abe S, Nonaka S, Suzuki H, et al
     Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
     Dis Esophagus. 2024 Jan 23:doae004. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. DE GROOT EM, Kingma BF, Goense L, van der Kaaij NP, et al
     Surgical treatment of esophago-tracheobronchial fistulas after esophagectomy.
     Dis Esophagus. 2024;37:doad054.
     PubMed     Abstract available
     
     
     
116. YAN S, Liu X, Xing W, Jiang D, et al
     The prognostic impact of tumor length on pathological stage IA-IC esophageal adenocarcinoma.
     Dis Esophagus. 2024;37:doad046.
     PubMed     Abstract available
     
     
     December 2023
117. SCHURING N, van Berge Henegouwen MI, Gisbertz SS
     History and evidence for state of the art of lymphadenectomy in esophageal cancer surgery.
     Dis Esophagus. 2023 Dec 4:doad065. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2023
118. AHMED N, Tankel J, Asselah J, Alcindor T, et al
     Survival and perioperative outcomes of octo- and nonagenarians with resectable esophageal carcinoma.
     Dis Esophagus. 2023;36:doad043.
     PubMed     Abstract available
     
     
     
119. WALMSLEY J, Ariyarathenam A, Berrisford R, Humphreys L, et al
     Systematic review of quality of life after esophagectomy and total gastrectomy in patients with gastro-esophageal junction cancer.
     Dis Esophagus. 2023;36:doad039.
     PubMed     Abstract available
     
     
     
120. 
     Correction to: 176. NON-REGIONAL LYMPHADENOPATHY IN PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH CURATIVE INTENT: A PROPENSITY MATCHED ANALYSIS OF PATHOLOGICAL AND SURVIVAL OUTCOMES.
     Dis Esophagus. 2023 Nov 21:doad067. doi: 10.1093.
     PubMed    
     
     
     October 2023
121. ELLIOTT JA, Guinan E, Reynolds JV
     Measurement and optimization of perioperative risk among patients undergoing surgery for esophageal cancer.
     Dis Esophagus. 2023 Oct 28:doad062. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. TIAN Y, Xue C, Li X, Bai J, et al
     Efficacy and safety of modified endoscopic submucosal tunnel dissection for superficial esophageal circumferential lesions.
     Dis Esophagus. 2023;36:doad035.
     PubMed     Abstract available
     
     
     
123. TAKEUCHI A, Ojima T, Hayata K, Kitadani J, et al
     Laparoscopic reconstruction in McKeown esophagectomy is a risk factor for postoperative diaphragmatic hernia.
     Dis Esophagus. 2023;36:doad037.
     PubMed     Abstract available
     
     
     
124. ALVARADO CE, Worrell SG, Sarode AL, Bassiri A, et al
     Disparities and access to thoracic surgeons among esophagectomy patients in the United States.
     Dis Esophagus. 2023;36:doad025.
     PubMed     Abstract available
     
     
     
125. DE GROOT E, Schiffmann LM, van der Veen A, Borggreve A, et al
     Laparoscopic ischemic conditioning prior esophagectomy in selected patients: the ISCON trial.
     Dis Esophagus. 2023;36:doad027.
     PubMed     Abstract available
     
     
     September 2023
126. REYHANI A, Gimson E, Baker C, Kelly M, et al
     Multiple staging investigations may not change management in patients with high-grade dysplasia or early esophageal adenocarcinoma.
     Dis Esophagus. 2023;36:doad020.
     PubMed     Abstract available
     
     
     
127. CROWE BR, Krigel A, Li T, Haile R, et al
     Veterans with multiple risk factors for Barrett's esophagus are infrequently evaluated with upper endoscopy.
     Dis Esophagus. 2023;36:doad007.
     PubMed     Abstract available
     
     
     
128. CHAN KS, Oo AM
     Exploring the learning curve in minimally invasive esophagectomy: a systematic review.
     Dis Esophagus. 2023;36:doad008.
     PubMed     Abstract available
     
     
     
129. YASUDA T, Matsuda A, Arai H, Kakinuma D, et al
     Feeding gastrostomy and duodenostomy using the round ligament of the liver versus conventional feeding jejunostomy after esophagectomy: a meta-analysis.
     Dis Esophagus. 2023;36:doac105.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.